Abstract
Neuropilins (NRPs) are receptors for class 3 Semaphorins and function as co-receptors for Vascular endothelial growth factor isoforms, VEGF165 and VEGF145 and related molecules. NRPs are expressed in a variety of neural and non-neural tissues and are required for normal development. Interestingly, class 3 Semaphorins and VEGF compete for common NRP binding. As a consequence, Semaphorins and VEGF appear to be mutually antagonistic. In the lung, NRP levels increase during development and NRPs and Semaphorins are involved in lung branching, probably by altering cell morphology or by regulating cell motility and migration. During lung tumorigenesis, both NRP and VEGF expression increase on dysplastic lung epithelial cells; SEMA3F expression is reduced and SEMA3F protein is delocalized from the membrane to the cytoplasm. In lung cancers, SEMA3F staining correlates inversely with tumor stage with high SEMA3F associated with less aggressive tumors. Conversely, more aggressive tumors are associated with increased VEGF staining and a corresponding loss in membranous SEMA3F.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fujisawa H, Kitsukawa T. Receptors for collapsin/Semaphorins. Curr. Opin. Neurobiol. 1998; 8:587–592
He Z, Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 1997; 90:739–751
Kolodkin A, Levengood D, Rowe E et al. Neuropilin is a Semaphorin III receptor. Cell 1997; 90:753–762
Soker S, Takashima S, Miao H et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998; 92:735–745
Unified nomenclature for the Semaphorins/collapsins. Semaphorin Nomenclature Committee. Cell 1999; 97:551–2
Raper J. Semaphorins and their receptors in vertebrates and invertebrates. Current Opinion in Neurobiology 2000; 10:88–94.
Chen H, Chedotal A, He Z et al. Neuropilin-2, a novel member of the Neuropilin family, is a high affinity receptor for the Semaphorins Sema E and Sema IV but not Sema III. Neuron 1997; 19:547–559.
Kitsukawa T, Shimizu M, Sanbo M et al. Neuropilin-Semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron 1997; 19:995–1005.
Chedotal A, Del Rio JA, Ruiz M et al. Semaphorins III and IV repel hippocampal axons via two distinct receptors. Development 1998; 125:4313–4323.
Chen H, He Z, Tessier-Lavigne M. Axon guidance mechanisms: Semaphorins as simultaneous repellents and anti-repellents. Nat. Neurosci. 1998; 1:436–439.
Giger RJ, Urquhart ER, Gillespie SK et al. Neuropilin-2 is a receptor for Semaphorin IV: insight into the structural basis of receptor function and specificity. Neuron 1998; 21:1079–1092.
Takahashi T, Nakamura F, Jin Z et al. Semaphorins A and E act as antagonists of Neuropilin1 and agonists of Neuropilin-2 receptors. Nat. Neurosci. 1998; 1:487–493.
Tamagnone L, Artigiani S, Chen H et al. Plexins are a large family of receptors for trans-membrane, secreted, and GPI-anchored Semaphorins in vertebrates. Cell 1999; 99:71–80.
Goshima Y, Nakamura F, Strittmatter P et al. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 1995; 376:509–514.
Deckers MM, Karperien M, van der Bent C et al. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 2000; 141:1667–74.
Midy V, Plouet J. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun 1994; 199:380–6.
Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts. Brain Res 1999; 846:219–28.
Byzova TV, Goldman CK, Pampori N et al. A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol Cell 2000; 6:851–60.
Gluzman-Poltorak Z, Cohen T, Herzog Y et al. Neuropilin-2 and Neuropilin-I are receptors for VEGF165 and PLGF- 2, but only Neuropilin-2 functions as a receptor for VEGFI45. J Biol Chem 2000; 275:18040–18045.
Kitsukawa T, Shimono A, Kawakami A et al. Overexpression of a membrane protein, Neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 1995; 121:4309–18.
Behar 0, Golden JA, Mashimo H et al. Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature 1996; 383:525–528.
Miao HQ, Soker S, Feiner L et al. Neuropilin-1 mediates collapsin-1/Semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 1999; 146:233–42.
Bagnard D, Vaillant C, Khuth ST et al. Semaphorin 3A-vascular endothelial growth factor165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor. J Neurosci 2001; 21:3332–41.
Hogan BL, Yingling JM. Epithelial/mesenchymal interactions and branching morphogenesis of the lung. Curr Opin Genet Dev 1998; 8:481–6.
Metzger RJ, Krasnow MA. Genetic control of branching morphogenesis. Science 1999; 284:1635–9.
Cardoso WV. Lung morphogenesis revisited: old facts, current ideas. Dev Dyn 2000; 219:121–30.
Warburton D, Schwarz M, Tefft D et al. The molecular basis of lung morphogenesis. Mech Dev 2000; 92:55–81.
Bellusci S, de Maximy A, Thiery JP. Controle moleculaire de la morphogenese pulmonaire chez la souris. Medecine Sciences 1999; 15:815–822.
Luo Y, Raible D, Raper A. Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 1993; 75:217–227.
Takahashi T, Nakamura F, Stittmatter S. Neuronal and non-neuronal collapsin-1 binding sites in developing chick are distinct from other Semaphorin binding sites. The Journal of Neuroscience 1997; 17:9183–9193.
Wang L, Strittmatter S. A family of rat CRMP genes is differentially expressed in the nervous system. J Neurosci 1996; 16:6197–6207.
Shih JY, Yang SC, Hong TM et al. Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. J Nat Cancer Inst 2001, 93, 1392–1400.
Ito T, Kagoshima M, Sasaki Y et al. Repulsive axon guidance molecule Sema3A inhibits branching morphogenesis of fetal mouse lung. Mech Dev 2000; 97:35–45.
Giger RJ, Cloutier JF, Sahay A et al. Neuropilin-2 is required in vivo for selective axon guidance responses to secreted Semaphorins. Neuron 2000; 25:29–41.
Chen H, Bagri A, Zupicich JA et al. Neuropilin-2 regulates the development of selective cranial and sensory nerves and hippocampal mossy fiber projections. Neuron 2000; 25:43–56
Taniguchi M, Yuasa S, Fujisawa H et al. Disruption of Semaphorin III/D gene causes severe abnormality in peripheral nerve projection. Neuron 1997; 19:519–530.
White FA, Behar O. The development and subsequent elimination of aberrant peripheral axon projections in Semaphorin3A null mutant mice. Dev Biol 2000; 225:79–86.
Kagoshima M, Ito T. Diverse gene expression and function of Semaphorins in developing lung: positive and negative regulatory roles of Semaphorins in lung branching morphogenesis. Genes Cells 2001; 6:559–71.
Goshima Y, Hori H, Sasaki Y et al. Growth cone Neuropilin-1 mediates collapsin-1/Sema III facilitation of antero-and retrograde axoplasmic transport. J Neurobiol 1999; 39:579–89
Bagnard D, Lohrum M, Uziel D et al. Semaphorins act as attractive and repulsive guidance signals during the development of cortical projections. Development 1998; 125:5043–5053
Song H, Ming G, He Z et al. Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides. Science 1998; 281:1515–1518.
Takahashi T, Fournier A, Nakamura F et al. Plexin-Neuropilin-1 complexes form functional Semaphorin-3A receptors. Cell 1999; 99:59–69.
Eickholt B, Mackenzie S, Graham A et al. Evidence for collapsin-1 functioning in the control of neural crest migration in both trunk and hindbrain regions. Development 1999; 126:2181–2189.
Roy PJ, Zheng H, Warren CE et al. mab-20 encodes Semaphorin-2a and is required to prevent ectopic cell contacts during epidermal morphogenesis in Caenorhabditis elegans. Development 2000; 127:755–767.
Brambilla E, Constantin B, Drabkin H et al. Semaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migration. Am J Pathol 2000; 156:939–950.
Roche J, Boldog F, Robinson M et al. Distinct 3p21.3 deletions in lung cancer, analysis of deleted genes and identification of a new human Semaphorin. Oncogene 1996; 12:1289–1297.
Xiang R, Hensel C, Garcia D et al. Isolation of the human Semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer. Genomics 1996; 32:39–48.
Sekido Y, Bader S, Latif F et al. Human Semaphorins A (V) and (IV) reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc Natl Acad Sci, USA 1996; 93:4120–4125.
Kok K, Naylor S, Buys C. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 1997; 71:27–92.
Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 2000; 60:6116–33.
Todd M, Xiang R, Garcia D et al. An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo. Oncogene 1996; 13:2387–2396.
Xiang R, Xhou X, Tse C et al. Expression of human Semaphorin 3F in a human ovarian cancer cell line (Hey) suppresses tumor formation in nude mice and blocks program cell death caused by adriamycin or taxol. 915tProceedings of the American Association for Cancer Research, Abstract 5216, San Francisco 2000.
Sundaresan V, Roberts I, Bateman A et al. The DUTTI Gene, a Novel NCAM Family Member Is Expressed in Developing Murine Neural Tissues and Has an Unusually Broad Pattern of Expression. Mol Cell Neurosci 1998; 11:29–35.
Kidd T, Brose K, Mitchell KJ et al. Roundabout controls axon crossing of the CNS midline and defines a novel subfamily of evolutionarily conserved guidance receptors. Cell 1998; 92:205–15.
Yamada T, Endo R, Gotoh M et al. Identification of Semaphorin E as non-MDR drug resistance gene of human cancers. Proc. Natl. Acad. Sci., USA 1997; 94:14713–14718.
Martin-Satue M, Blanco J. Identification of Semaphorin E gene expression in metastatic human lung adenocarcinoma cells by mRNA differential display. J Surg Oncol 1999; 72:18–23
Christensen CR, Klingelhofer J, Tarabykina S et al. Transcription of a novel mouse Semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines. Cancer Res 1998; 58:1238–1244.
Dorfman D, Shahsafaei A, Nadler L et al. The leukocyte Semaphorin CD100 is expressed in most T-cell, but few B-cell, non-Hodgkin’s lymphomas. Am. J. Pathol. 1998; 153:255–262
Hirsch E, Hu L-J, Prigent A et al. Distribution of Semaphorin IV in adult human brain. Brain Res. 1999; 823:67–79.
Miao HQ, Lee P, Lin H et al. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. Faseb J 2000; 14:2532–9.
Bachelder RE, Crago A, Chung J et al. Vascular endothelial growth factor is an autocrine survival factor for Neuropilin-expressing breast carcinoma cells. Cancer Res 2001; 61:5736–40.
Latil A, Bieche I, Pesche S et al. VEGF overexpression in clinically localized prostate tumors and Neuropilin-1 overexpression in metastatic forms. Int J Cancer 2000; 89:167–71
Ding H, Wu X, Roncari L et al. Expression and regulation of Neuropilin-1 in human astrocytomas. Int J Cancer 2000; 88:584–92.
Banerjee SK, Zoubine MN, Tran TM et al. Overexpression of vascular endothelial growth factor164 and its co-receptor Neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells. Int J Oncol 2000; 16:253–60.
Gagnon ML, Bielenberg DR, Gechtman Z et al. Identification of a natural soluble Neuropilin1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity. Proc Natl Acad Sci USA 2000; 97:2573–8.
Brabletz T, Jung A, Hermann K et al. Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 1998; 194:701–4.
Graff JR, Gabrielson E, Fujii H et al. Methylation patterns of the E-cadherin 5’ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 2000; 275:2727–32.
Tomizawa Y, Sekido Y, Kondo M. et al. Inhibition of lung cancer cell growth and induction of apoptosis following re-expression of 3p21.3 tumor suppressor gene candidate SEMA3B. Proc Natl Acad of Sci USA 2001; 98:13954–13959.
Gagliardini V, Fankhauser C. Semaphorin III Can Induce Death in Sensory Neurons. Mol Cell Neurosci 1999; 14:301–316.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Roche, J., Drabkin, H., Brambilla, E. (2002). Neuropilin and Its Ligands in Normal Lung and Cancer. In: Bagnard, D. (eds) Neuropilin: From Nervous System to Vascular and Tumor Biology. Advances in Experimental Medicine and Biology, vol 515. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0119-0_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0119-0_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4932-7
Online ISBN: 978-1-4615-0119-0
eBook Packages: Springer Book Archive